A Cardiac Magnetic Resonance Study: Comparison of Biventricular Longitudinal Function in Hypertrophic Cardiomyopathy Patients and Normal Individuals.

Abstract

Hypertrophic cardiomyopathy (HCM) is a genetic disease with an incidence of0.2%-0.5%. It has a wide range of clinical presentations varying from coincidental diagnoses to heart failure, ventricular arrhythmias and sudden cardiac death.Mitral annular plane systolic excursion (MAPSE) and tricuspid annular plane systolic excursion (TAPSE) are M-mode-derivedpractical and reproduciblemeasurements of systolic longitudinal displacement of the annular plane. These two measuresmay be used as markers of the left ventricular and right ventricular longitudinal functions. Currently, there are only a fewstudies on cardiac magnetic resonance (CMR)-derived TAPSE and MAPSE measurement comparison between the HCM group andnormal control group. The aim of our study is to show the differences in CMR-derived TAPSE and MAPSE valuesbetween the HCM and normal population. We evaluatedCMR exams of patients diagnosed with HCM andof normal individuals scanned between 2020 and 2021 retrospectively. The patients were from our own institution's and other hospitals'in- and out-patient departments. Data was collected on36 HCMpatients and 34 adults with no known history ofcardiac and non-cardiac diseases. All CMR exams were performed on a 1.5 T (Magnetom Avanto, Siemens Healthcare, Erlangen, Germany) scanner.CMR-derived MAPSE and TAPSE were measured on standard four-chamber steady-state free precession (SSFP) cine images and given in millimeters. From February 2020to December 2021, a total of 150 patients were diagnosed with hypertrophic cardiomyopathy. After exclusion, 36 patients with HCM were included in the study and the normal control group comprised 34 individuals. The mean age of the HCM groupwas 43.2+ 13.5 years, while it was 37.5 + 11.3 in the control group. The female ratio of the HCM group was found to be 36%, while it was56% in the healthy control group.MAPSEvalues were significantly higher in the normal control group when compared to the HCM patient group (MAPSE: 14.5 ± 2.9 mm vs. 11.7 ± 3.2 mm; p<0.001), while TAPSE values did not depict a significant difference between the two groups (p=0.627). This study suggests that MAPSE values are significantly lower in the HCM patient group in comparison with the normal control group on CMRscans. Although not statistically significant, TAPSE values are also lower in the HCMgroup.